MD

Fresenius Kabi Oncology Limited is a public company primarily operating in the field of Research & Development and manufacturing of world-class oncology drugs.

As one of the world’s leading global clinical research organizations (CRO), we provide the clinical development capabilities and integrated consulting expertise it takes to streamline development every step of the way — faster and more cost-effectively.